A detailed history of Capital Research Global Investors transactions in Cabot Corp stock. As of the latest transaction made, Capital Research Global Investors holds 462,691 shares of CBT stock, worth $42.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
462,691
Previous 462,691 -0.0%
Holding current value
$42.8 Million
Previous $42.5 Million 21.59%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$90.69 - $102.77 $5.33 Million - $6.04 Million
-58,795 Reduced 11.27%
462,691 $42.5 Million
Q1 2024

May 14, 2024

BUY
$71.14 - $92.2 $6.91 Million - $8.95 Million
97,101 Added 22.88%
521,486 $48.1 Million
Q3 2023

Nov 13, 2023

BUY
$65.61 - $74.12 $3.16 Million - $3.57 Million
48,229 Added 12.82%
424,385 $29.4 Million
Q2 2023

Aug 11, 2023

BUY
$63.92 - $76.74 $23.1 Million - $27.7 Million
361,373 Added 2444.52%
376,156 $25.2 Million
Q1 2023

May 15, 2023

BUY
$65.68 - $83.66 $970,947 - $1.24 Million
14,783 New
14,783 $1.13 Million

Others Institutions Holding CBT

About CABOT CORP


  • Ticker CBT
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 56,299,200
  • Market Cap $5.21B
  • Description
  • Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through three segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The company offers reinforcing carbons used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such...
More about CBT
Track This Portfolio

Track Capital Research Global Investors Portfolio

Follow Capital Research Global Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.